BusinessEpigral Targets ₹5,000 Crore Revenue by FY31 with Capacity Expansion
Specialty chemicals manufacturer Epigral aims to achieve ₹5,000 crore revenue by 2030-31, driven by doubling production capacities of CPVC Resin and Epichlorohydrin (ECH) at its Dahej, Gujarat units. The company expects ₹2,900 crore revenue in the current fiscal year, up from ₹2,500-2,530 crore in FY26. Capacity expansions, costing ₹650 crore, will start contributing significantly from next year.
Business Standard·3h ago·Dahej


